Tagrisso Osimertinib Tablets
Brand Name: Tagrisso
Active Ingredient: Osimertinib 80mg
Manufactured by: AstraZeneca
Packing: Pack of 30 Tablets
What is Tagrisso Osimertinib 80mg Tablets?
Tagrisso (Osimertinib) Tablets may be a cancer medication that interferes with the expansion and unfolds of cancer cells within the body.
Tagrisso Tablets is employed to treat an exact sort of non-small cell carcinoma. This medication is employed as long as your neoplasm includes a specific gene, that your doctor can check. Tagrisso Osimertinib Tablets is sometimes given when different cancer medicines are tried while not a success.
Tagrisso 80mg was approved by the United States Food associate degreed Drug Administration (FDA) on an "accelerated" basis. In clinical studies, tumors felt this medication. However, additional studies area unit required to work out if this medication will lengthen survival time.
Please consult with your doctor or specialist and follow their instructions on what dosage to take, how often to take, when to take and for how long to take the drug. Usual recommended dose is one tablet (80 mg) daily - taken orally with or without food. Treatment must be stopped if cancer deteriorates or intolerable adverse events occur. For patients experiencing difficulties swallowing, the tablet can be dissolved in 50 ml of water and administered through a nasogastric tube.
Please consult with your doctor or specialist before taking this drug.
Tagrix (Osimertinib) Tablets can lead to lung and heart disorders. Please contact your physician in case you feel any related symptoms, such as:
Shortness of breath;
Increased heart rate;